Scan how Butterfly Network's raised guidance and capital plans compare with peers tapping AI-driven medical imaging momentum through our hand picked list of 35 healthcare AI stocks.
To own Butterfly Network, you need to believe its semiconductor based ultrasound platform and AI tools can turn growing demand for portable imaging, bladder scanners and embedded partnerships into durable, high margin revenue. The latest quarter shows higher revenue and a smaller loss, which supports that narrative, but the business is still loss making and depends on execution in newer channels.
The raised 2026 revenue outlook and improved loss profile keep the near term focus on whether Embedded, enterprise and Home and Community Care deals can offset softer core POCUS and international trends. The biggest immediate risk remains that these newer streams scale slower than expected while equity issuance from the fresh financing framework dilutes you.
The raised full year 2026 revenue guidance to US$123 million to US$126 million, with Q4 revenue expected between US$31 million and US$34 million, is the clearest operational signal in this update. It connects directly to the main catalyst investors watch: whether Butterfly Network can turn its technology roadmap, enterprise contracts and Home and Community Care roll out into consistent top line progress.
If the company stays on track with this outlook while keeping losses moving in the right direction, it could support the case that embedded chip deals and software oriented contracts are gaining traction. If growth stalls against that guidance or loss reduction reverses, the combination of an at the market equity program and a universal shelf increases the risk that more capital raising and potential dilution dominates the story.
Butterfly Network's current loss of US$53.7 million is set against analyst expectations for earnings of US$29.4 million on forecast revenue of US$228.4 million by 2029. That shift implies revenue growing at 22.8% a year and an earnings swing of about US$83.1 million if the profit outlook reaches that 2029 consensus.
Uncover why Butterfly Network's fair value indicates a 75% potential upside to its current price, which could narrow quickly.
One alternate angle around Butterfly Network focuses on dilution risk rather than revenue guidance. The most bearish analysts were working off 3 year revenue growth assumptions of 24.7% a year and forecasting earnings of about US$27.3 million by 2029, while also expecting shares outstanding to climb roughly 5.4% annually. That view treats future equity issuance and a US$10.0 price target as central. It is much more cautious than the wider group. Since those projections were set before this earnings beat and guidance raise, you can use them as a reference point and then decide how the new numbers might shift your own view.
Explore 4 other Butterfly Network fair value estimates, including one that suggests as much as 72% downside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If Butterfly Network has sharpened your view on where AI, healthcare and profitability trade offs meet, it can help to line that up against a broader watchlist built from different angles on quality, value and resilience.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com